Trial · NCT01613118
Adverse event totals15
The totals the trial posted for each group.
1 to 15 of 15
Download this page as JSON| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | RE-021 (Sparsentan) 200 mg - Double-Blind Period | 0 | 13 |
| Total, all-cause mortality | RE-021 (Sparsentan) 400 mg - Double-Blind Period | 0 | 26 |
| Total, all-cause mortality | RE-021 (Sparsentan) 800 mg - Double-Blind Period | 0 | 34 |
| Total, all-cause mortality | Irbesartan 300 mg - Double-Blind Period | 0 | 36 |
| Total, all-cause mortality | All Sparsentan (Double-Blind and Open-Label Extension) | 0 | 108 |
| Total, other adverse events | RE-021 (Sparsentan) 200 mg - Double-Blind Period | 11 | 13 |
| Total, other adverse events | RE-021 (Sparsentan) 400 mg - Double-Blind Period | 17 | 26 |
| Total, other adverse events | RE-021 (Sparsentan) 800 mg - Double-Blind Period | 27 | 34 |
| Total, other adverse events | Irbesartan 300 mg - Double-Blind Period | 26 | 36 |
| Total, other adverse events | All Sparsentan (Double-Blind and Open-Label Extension) | 104 | 108 |
| Total, serious adverse events | RE-021 (Sparsentan) 200 mg - Double-Blind Period | 0 | 13 |
| Total, serious adverse events | RE-021 (Sparsentan) 400 mg - Double-Blind Period | 0 | 26 |
| Total, serious adverse events | RE-021 (Sparsentan) 800 mg - Double-Blind Period | 2 | 34 |
| Total, serious adverse events | Irbesartan 300 mg - Double-Blind Period | 1 | 36 |
| Total, serious adverse events | All Sparsentan (Double-Blind and Open-Label Extension) | 48 | 108 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01613118/event-totals